alzheimer semaglutide biomarkers Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Semaglutide's Setback in Alzheimer Disease

Clinical implications and biomarker development Liquid biopsy for dynamic monitoring: ctDNA, circulating tumor cells (CTCs), and exosomes Liquid biopsy, through the analysis of ctDNA, CTCs, and extracellular vesicles (EVs) in peripheral blood or other body fluids, provides a minimally invasive and real-time approach for early cancer detection, treatment monitoring, and resistance mechanism identification (Fig

, : - : ,

Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans

Scavone, F., Gumbin, S

We need more targeted studies on low-dose and microdose effects, but the clinical signals are encouraging